These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10613651)

  • 41. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
    J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
    Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
    Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis.
    Kijiyama N; Ueno H; Sugimoto I; Sasaguri Y; Yatera K; Kido M; Gabazza EC; Suzuki K; Hashimoto E; Takeya H
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1113-9. PubMed ID: 16338226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
    Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
    Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats.
    Akahane K; Okamoto K; Kikuchi M; Todoroki H; Higure A; Ohuchida T; Kitahara K; Takeda S; Itoh H; Ohsato K
    Surgery; 2001 Nov; 130(5):809-18. PubMed ID: 11685190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
    Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
    Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disseminated intravascular coagulation (DIC).
    Mammen EF
    Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin-dependent) diabetes.
    Ibbotson SH; Catto A; Davies JA; Grant PJ
    Thromb Haemost; 1995 Feb; 73(2):243-6. PubMed ID: 7792737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA; Seitz I; Busch G; Stein A; Ott I
    Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa.
    Lormeau JC; Herault JP
    Thromb Haemost; 1995 Dec; 74(6):1474-7. PubMed ID: 8772223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An assay to evaluate heparanase procoagulant activity.
    Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
    Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
    Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
    Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
    Takahashi H; Sato N; Shibata A
    Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue factor and its inhibition at the human microvascular anastomosis.
    Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC
    J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.